Calamos Advisors LLC
Q2 2020 13F-HR Holdings
Net value change ($000)
+1,402,622
(11.0%)
New positions
90
Sold out positions
100
Turnover %
7.0%
Sector allocation + QoQ delta (equities-only)
Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown
Snapshot: Change Analysis
Compared to Q1 2020
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| MSFT | 119,485 | 27.9% |
| AAPL | 93,232 | 29.2% |
| AMZN | 89,386 | 27.5% |
| BSX | 59,665 | NEW |
| META | 54,944 | 31.9% |
| RTX | 50,377 | NEW |
| NVDA | 29,067 | 35.2% |
| PYPL | 25,824 | 80.9% |
| SWK | 25,760 | 68.9% |
| VRTX | 22,635 | 83.0% |
Top Reduces (Value $000, Stocks/ETFs)
| SPY | -172,857 | -99.9% |
| Allergan plc | -67,018 | -100.0% |
| BDX | -51,095 | -100.0% |
| RAYTHEON CO/ | -32,880 | -100.0% |
| NOW | -28,316 | -71.1% |
| RSG | -24,450 | -100.0% |
| CBOE | -23,781 | -68.8% |
| ALXN | -23,294 | -63.6% |
| VZ | -20,487 | -32.7% |
| LH | -20,073 | -51.0% |
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000):
590,302
(4.2% of total reported value)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|